SUO at the AUA
May 17, 2008
The Rosen Centre Hotel, Orlando, Florida

SUO Needs:
Urologic oncologists need to know the appropriate management of patients with elevated PSA and a negative prior biopsy; the role of surgery and radiation therapy in high risk localized disease; the best approach to high grade superficial bladder carcinoma; and the optimal strategy for patients with small renal masses.

SUO Objectives:
At the conclusion of the meeting, the attendee will be able to:

1. Discuss biopsy strategies for patients with prior negative biopsies.
2. Distinguish the novel markers for prostate cancer.
3. Assess the rationale both radiation therapy and surgery for locally aggressive but non metastatic prostate carcinoma.
4. Explain the treatment options for patients with T1 grade 3 bladder carcinoma who have failed prior intravesical therapy.
5. Determine the indications for biopsy of renal masses.
6. Describe ways to optimize the diagnosis and treatment of bladder cancer at every stage.
7. Indentify the balance between observation and minimally invasive treatments for the small renal mass.

Morning - SBUR/SUO Educational Needs
Physicians need a better understanding of new technologies and concepts that are changing the way that we conduct translational research. This session will focus on new areas of optical imaging, small non-coding RNAs, and cancer stem cells. Participants will learn these tools will enable more effective research, diagnosis and treatment of individuals with urologic diseases.

Morning - SBUR/SUO Educational Objectives

1. Provide basic foundational knowledge in the areas of optical imaging, cancer stem cell biology, and small non-coding RNAs.
2. Present practical applications of basic information to study and treatment of human disease.
3. Foster discussion of novel applications of these technologies in both clinical and experimental studies of a wide rage of urologic malignancies.

Accreditation Statement: The American Urological Association
(AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AUA takes responsibility for the content, quality, and scientific integrity of this CME activity.

Credit Designation: The American Urological Association designates this educational activity for a maximum of 6.00 AMA PRA Category 1 Credit(s)™. Physicians should claim credit commensurate with the extent of their participation in the activity.

AUA Disclosure Policy: As a provider accredited by the ACCME, the AUA must ensure balance, independence, objectivity, and scientific rigor in all its activities.

All faculty participating in an educational activity provided by the AUA are required to disclose to the audience any relevant financial relationships with any commercial interest to the provider. The intent of this disclosure is not to prevent faculty with relevant financial relationships from serving as faculty, but rather to provide members of the audience with information on which they can make their own judgments. The AUA must resolve any conflicts of interest prior to the commencement of the educational activity. It remains for the audience to determine if the faculty’s relationships may influence the educational content with regard to exposition or conclusion. When unlabeled or unapproved uses are discussed, these are also indicated.

Unlabeled or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to unlabeled or unapproved uses or drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Evidence Based Content: As a provider of continuing medical education, accredited by the ACCME, it is the policy of the AUA to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

Special Assistance: We encourage participation by all individuals. If you have a disability, advance notification of any special needs will help us better serve you. Call 847-264-5901 if you require special assistance to fully participate in the meeting.

Society of Urologic Oncology Program
Saturday, May 17, 2008
Junior Ballroom F, Rosen Center
Orlando FL

The Morning Session is a combined meeting of: The Society of Basic Urologic Research & The Society of Urologic Oncology